At Good AI, we believe that the next wave of AI innovations is emerging from leading research institutions from both Silicon Valley and beyond. Built upon our partnerships with industry leaders, we have successfully helped commercialize some of these institutions’ most transformative intellectual properties in Nanotechnology, Autonomous Driving, Robotics, Deep Learning, Synthetic Biology, CRISPR, Genomic Sequencing, Microbiome, Cell and Gene Therapies, and Precision Medicine

Building Successful Companies Together

Based on a high conviction strategy, Good AI Capital invests in a small number of high-quality startups where we can add value and contribute towards their long-term success.